Los Angeles 21 CFR 820 Compliance Consultants

21 CFR 820 Compliance Consultants · Los Angeles

21 CFR 820 Compliance Consultants in Los Angeles: Build an Audit-Ready Quality System

A single regulatory misstep can mean costly delays and submission setbacks. MedLaunch gives LA device developers a clear, proven path to FDA quality system compliance.

  • An efficient, audit-ready QMS built for your device
  • Pristine documentation and robust processes
  • A team prepared for any FDA inspection
Free for LA Med-Tech Teams

Get Your Free 21 CFR 820 Quality System Gap Review

  • 30-minute call with a quality systems consultant
  • Quick check of your QMS against 21 CFR 820 and ISO 13485 expectations
  • Clear guidance on gaps and next steps
This field is for validation purposes and should be left unchanged.
Max. file size: 50 MB.

🔒 No obligation. Your information stays confidential.

21 CFR Part 820 (QMSR)ISO 13485:2016FDA inspection readinessLocal LA collaborationExplore MedLaunch Tools ↓

Bringing a medical device to market from the vibrant Los Angeles hub is an incredible accomplishment. But turning your innovative vision into a reality means navigating the FDA’s complex regulatory landscape. For developers focused on creating the next breakthrough technology, understanding and implementing the quality system requirements in 21 CFR 820 can feel like a significant hurdle.

A single misstep can lead to costly delays, submission rejections, and major setbacks. You need a clear, proven strategy to ensure compliance and keep your project moving forward. MedLaunch simplifies this process, providing the expert guidance you need to succeed.

Update: 21 CFR 820 Is Now the QMSR

The FDA’s Quality System Regulation (QSR) has been replaced by the Quality Management System Regulation (QMSR), effective February 2, 2026. Part 820 now incorporates ISO 13485:2016 by reference. Here is what that means for your team:

1

ISO 13485 is the core

Your QMS must meet the applicable requirements of ISO 13485:2016, plus FDA-specific provisions in Part 820.

2

New terminology

“Design controls” is now design and development under ISO 13485, and the underlying expectations remain largely the same.

3

New inspection process

FDA retired QSIT and now inspects under Compliance Program 7382.850, a risk-based approach.

4

More transparency

Management review, internal audit, and supplier audit reports are no longer shielded from FDA review.

Understanding 21 CFR 820: The Foundation of Quality

The FDA’s 21 CFR 820 regulation is the blueprint for your Quality Management System (QMS). It is not just a set of rules; it is a framework designed to ensure your device is safe, effective, and consistently produced to the highest standards. Adherence is non-negotiable for market access in the United States.

While the regulation covers the entire product lifecycle, several key areas are critical for developers to master:

Design Controls

A systematic process to ensure your device meets user needs and its intended use. Document every step from initial concept to final design transfer, creating a clear and traceable history.

Now: ISO 13485 clause 7.3, design and development.

Document Controls

Established procedures to control all relevant documents: how they are created, approved, distributed, and revised, so your team always works from the most current information.

Now: ISO 13485 clause 4.2.4, control of documents.

Corrective and Preventive Action (CAPA)

A structured system for identifying and resolving quality issues. A strong CAPA process fixes existing problems, prevents recurrence, and drives continuous improvement.

Now: ISO 13485 clauses 8.5.2 and 8.5.3.

Claim your free quality system gap review

Get My Free Review

Streamline Your QMS with MedLaunch

We turn these complicated regulatory requirements into clear, manageable steps. MedLaunch partners with Los Angeles-based firms to build and maintain an efficient, audit-ready QMS that satisfies all 21 CFR 820 requirements. We provide the hands-on support needed to translate dense regulations into practical, day-to-day processes for your team.

Our approach helps you establish a foundation of quality from the start, reducing compliance risks and preventing expensive delays down the line. We ensure your documentation is pristine, your processes are robust, and your team is prepared for any FDA inspection.

What an Audit-Ready QMS Includes

  • Quality manual, policy, and objectives
  • Design and development procedures with a traceable design history
  • Document and record control
  • CAPA, complaint handling, and nonconformance processes
  • Supplier and purchasing controls
  • Management review and internal audit programs

MedLaunch Tools: Interactive Regulatory Resources

Many Los Angeles device companies plan for the U.S. and EU at the same time. Use these MedLaunch tools to explore digital health, EU MDR, and clinical evaluation questions alongside your 21 CFR 820 quality system work.

Digital Health

Digital Health Regulatory Navigator

Explore the regulatory considerations for digital health and software-driven products.

Open Tool

EU MDR

MDCG 2020-5 Companion

A companion for working through MDCG 2020-5, the EU guidance on clinical evaluation and equivalence.

Open Tool

EU MDR

EUMDR Roadmap

Map out your path to EU MDR compliance.

Open Tool

EU MDR

EUMDR Factory

An interactive MedLaunch tool to support your EU MDR work.

Open Tool

Local Support for the LA Med-Tech Hub

Los Angeles is home to startups and established manufacturers building diagnostics, wearables, surgical tools, and software-driven devices. Each has different quality system needs, so your QMS should be sized to your device, your team, and your stage rather than copied from a template.

  • Faster collaboration: Work closely with your engineering and quality teams.
  • Practical processes: Procedures your team can actually follow day to day.
  • Inspection confidence: Records and routines that stand up to FDA review.

Key Takeaways

What is 21 CFR 820?

It is the FDA regulation that sets quality system requirements for medical device manufacturers. Since February 2, 2026, it is known as the Quality Management System Regulation (QMSR).

Does 21 CFR 820 apply to my device?

It generally applies to manufacturers of finished medical devices marketed in the United States, with limited exemptions for some device types. A consultant can confirm how it applies to your product.

Why does it matter?

A compliant, audit-ready quality system supports FDA submissions and inspections and helps you avoid costly delays and rework.

21 CFR 820 Frequently Asked Questions

Is 21 CFR 820 still called the QSR?

The Quality System Regulation was renamed the Quality Management System Regulation (QMSR) when the updated rule took effect on February 2, 2026. The regulation still lives in 21 CFR Part 820, but it now incorporates ISO 13485:2016 by reference.

Do I need ISO 13485 certification to sell in the U.S.?

FDA requires your quality management system to meet the applicable requirements of ISO 13485:2016 as incorporated into Part 820, but it does not require a certificate. Certification also does not replace an FDA inspection, and the QMSR includes FDA-specific provisions that go beyond the ISO standard.

What happened to design controls under the QMSR?

The QMSR no longer uses the term design controls. Those requirements now sit under the design and development clause of ISO 13485 (clause 7.3), and the underlying expectations remain largely the same: planned design inputs and outputs, reviews, verification, validation, transfer, and a traceable design history.

How does CAPA work under the QMSR?

Corrective and preventive action requirements now map to ISO 13485 clauses 8.5.2 and 8.5.3. You still need a documented process to investigate root causes, take action, verify effectiveness, and prevent recurrence, with records that show the full trail.

What changed for FDA inspections?

FDA retired the Quality System Inspection Technique (QSIT) on February 2, 2026 and now inspects under Compliance Program 7382.850, a risk-based process. The QMSR also removed the old exception that kept management review, internal audit, and supplier audit reports from FDA review, so be ready to share them.

When should a startup build its quality system?

As early as possible. Design and development requirements apply during development, even for devices under an investigational device exemption. Building your QMS before design transfer gives you clean records, fewer surprises, and a smoother path to your first inspection.

How long does it take, and what does it cost?

It depends on your device, your team, and how much documentation already exists. We scope the work after reviewing your current quality system, which is why we start with a free gap review.

Get a Clear Path to Compliance

Don’t let regulatory challenges stand between you and a successful product launch. Let our experts provide the strategic support and clear guidance needed to navigate the FDA’s requirements with confidence. Contact MedLaunch today to schedule a consultation or a comprehensive audit of your quality system. Let’s build your clear path to market success.


Experience Backed by Results
Real Solutions. Proven Results.

We don’t just talk about getting results; we deliver them. See how MedLaunch helps medical device companies overcome complex challenges and bring innovative products to market.

Revital Image
Revitalizing a Legacy Medical Device

Turning an Outdated Product Into a Modern Market Success

Extending Image
Extending the Shelf Life of a Critical Medical Device

Solving Regulatory & Supply Chain Challenges to Keep a Life-Saving Product on the Market

Ready To Move Forward?

Every great device deserves a clear path to market.
Connect with MedLaunch today and take the first step toward approval and success.

This field is for validation purposes and should be left unchanged.
Max. file size: 50 MB.